1. Investigation of the Active Ingredients and Mechanism of Polygonum cuspidatum in Asthma Based on Network Pharmacology and Experimental Verification
   Junjie Bi et al, 2021, Drug Design, Development and Therapy CrossRef
2. Current Insight into Novel Delivery Approaches of Resveratrol for Improving Therapeutic Efficacy and Bioavailability with its Clinical Updates
   Ranjit K. Harwansh et al, 2023, Current Pharmaceutical Design CrossRef
3. Targeting Inflammation Driven by HMGB1
   Huan Yang et al, 2020, Frontiers in Immunology CrossRef
4. The Ability of Resveratrol to Attenuate Ovalbumin-Mediated Allergic Asthma Is Associated With Changes in Microbiota Involving the Gut-Lung Axis, Enhanced Barrier Function and Decreased Inflammation in the Lungs
   Esraah Alharris et al, 2022, Frontiers in Immunology CrossRef
5. The Role and Mechanisms of Traditional Chinese Medicine for Airway Inflammation and Remodeling in Asthma: Overview and Progress
   Bo-wen Zhou et al, 2022, Frontiers in Pharmacology CrossRef
6. PM2.5 Exposure and Asthma Development: The Key Role of Oxidative Stress
   Kaimeng Liu et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
7. Antiproliferative effects of resveratrol and indole-3-carbinol in HPV-associated diseases prevention
   K. I. Gusakov et al, 2022, Meditsinskiy sovet = Medical Council CrossRef
8. Resveratrol Can Attenuate Astrocyte Activation to Treat Spinal Cord Injury by Inhibiting Inflammatory Responses
   Ruihua Fan et al, 2021, Molecular Neurobiology CrossRef
9. Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways
   Hamidreza Poortalebi et al, 2024, Current Medicinal Chemistry CrossRef
10. Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways
    Yihua Piao et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
11. S14G-Humanin ameliorates ovalbumin-induced airway inflammation in asthma mediated by inhibition of toll-like receptor 4 (TLR4) expression and the nuclear factor κ-B (NF-κB)/early growth response protein-1 (Egr-1) pathway
    Bo Su et al, 2023, Aging CrossRef
12. Association of Toll-like receptors 4 (TLR-4) gene expression and polymorphisms in patients with severe asthma
    Wasan Shukur et al, 2021, Journal of Medicine and Life CrossRef
13. A comprehensive insight into the molecular and cellular mechanisms of action of resveratrol on complications of sepsis a systematic review
    Mahdi Vajdi et al, 2023, Phytotherapy Research CrossRef
14. LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis
    Zhanqiang Zheng et al, 2021, Molecular and Cellular Biochemistry CrossRef
15. Flavonoids-mediated TLR4 Inhibition as a Promising Therapy for Renal Diseases
    Ayman M. Mahmoud et al, 2023, Combinatorial Chemistry & High Throughput Screening CrossRef
16. An overview of high-mobility group box 1, a potent pro-inflammatory cytokine in asthma
    Farzaneh Kianian et al, 2020, Journal of Basic and Clinical Physiology and Pharmacology CrossRef
17. Majie Cataplasm Alleviates Asthma by Regulating Th1/Th2/Treg/Th17 Balance
    Yuanjun Liu et al, 2024, International Archives of Allergy and Immunology CrossRef